Samar Alsafadi

1.5k citations

24 papers · 672 indexed · h-index 12

Impact in

Ophthalmology top 5%
- Ocular Oncology and Treatments
Cancer Research

Papers in

Ophthalmology 9
- Ocular Oncology and Treatments 9
Cell Biology 6
- Hippo pathway signaling and YAP/TAZ 5

Co-authors: Sergio Roman‐Roman Marc‐Henri Stern Alexandre Houy Tatiana Popova Michel Wassef Sophie Piperno‐Neumann Angelos Constantinou Aude Battistella
Journals: Cancers (4 papers)European Journal of Cancer (2 papers)Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Scientific Reports (1 paper)
Partner nations: France Netherlands United States

In The Last Decade

Samar Alsafadi

24 papers receiving 666 citations

Peers

Countries citing papers authored by Samar Alsafadi

Since Specialization

Citations

This map shows the geographic impact of Samar Alsafadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Alsafadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Alsafadi more than expected).

Fields of papers citing papers by Samar Alsafadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Alsafadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Alsafadi. The network helps show where Samar Alsafadi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Samar Alsafadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samar Alsafadi Line = papers co-authored together Samar Alsafadi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma Cancers ·P. Gruner, Fariba Némati, Didier Decaudin, Teboho Motaboli, Vazeer Mahamood, 尊史木下, Ashyapak Shevetha, Aart G. Jochemsen, Sophie Gardrat, Sophie Piperno‐Neumann, Manuel Rodrigues, Pascale Mariani, Nathalie Cassoux, Marc‐Henri Stern, Sergio Roman‐Roman, Samar Alsafadi	2023	9
2	Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target Cell Death Discovery ·Arwin Groenewoud, Jie Yin, Maria Chiara Gelmi, Samar Alsafadi, Fariba Némati, Didier Decaudin, Sergio Roman‐Roman, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Martine J. Jager, Felix B. Engel, B. Ewa Snaar‐Jagalska	2023	8
3	L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases Laboratory Investigation ·Raymond L. Barnhill, Steven Van Laere, Peter Vermeulen, Sergio Roman‐Roman, Sophie Gardrat, Samar Alsafadi, P. Gruner, Gabriel Champenois, Nicolás André, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Manuel Rodrigues, Richard A. Scolyer, Alexander J. Lazar, Emanuela Romano, Sophie Piperno‐Neumann, Pascale Mariani, Claire Lugassy	2022	9
4	Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency npj Precision Oncology ·M Poser, Fariba Némati, Aurélie Herbette, Verbiest Annelies, Stéphane Dayot, Olivier Ganier, Samar Alsafadi, Sophie Gardrat, Pascale Mariani, Mónica Pérez Castañeda, 直己鷲山, Vincent Servois, Nathalie Cassoux, Didier Decaudin, Sergio Roman‐Roman, Elaine Del Nery, Sophie Piperno‐Neumann, Marc‐Henri Stern, Manuel Rodrigues	2022	2
5	Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma Investigative Ophthalmology & Visual Science ·Е.Г. Руденкова, Fariba Némati, Amina F.A.S. Teunisse, Maria Chiara Gelmi, Penny Garvin, Hafsa Mohammadi, Samar Alsafadi, Martine J. Jager, Didier Decaudin, Aart G. Jochemsen	2022	3
6	Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution Computational and Structural Biotechnology Journal ·Teboho Motaboli, P. Gruner, Alexandre Houy, Dorine Bellanger, Tatiana Popova, Marc‐Henri Stern, Sergio Roman‐Roman, Samar Alsafadi	2021	13
7	Germline MBD4 Mutations and Predisposition to Uveal Melanoma JNCI Journal of the National Cancer Institute ·K. Ray, Manuel Rodrigues, Мирослава Бенкова-Петрова, Stéphane Dayot, Alexandre Houy, Lenha Mobuchon, Sophie Gardrat, Delphine Lequin, Stelly Ballet, Gaëlle Pierron, Samar Alsafadi, Odette Mariani, Ahmed El Marjou, Alexandre Matet, Chrystelle Colas, Nathalie Cassoux, Marc‐Henri Stern	2020	38
8	Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers Oncogene ·Samar Alsafadi, Stéphane Dayot, P. Gruner, Alexandre Houy, Dorine Bellanger, Xiwei Yao, Michel Wassef, Joshua J. Waterfall, Erik Lehnert, Sergio Roman‐Roman, Marc‐Henri Stern, Tatiana Popova	2020	20
9	Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma European Journal of Cancer ·Didier Decaudin, El Seed, Fariba Némati, P. Gruner, Alexis Barr, Mohamed Zerara, Vazeer Mahamood, Akanksha, Ensar Halilovic, Claire Fabre, Aart G. Jochemsen, Sergio Roman‐Roman, Samar Alsafadi	2020	20
10	Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology Cancers ·Akanksha, P. Gruner, Sergio Roman‐Roman, Samar Alsafadi	2019	34
11	Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model Scientific Reports ·André Luiz Souza Gomes, Raymond L. Barnhill, Claire Lugassy, Laurent A. Bentolila, Nathalie Cassoux, Sergio Roman‐Roman, Samar Alsafadi, Filippo Del Bene	2018	35
12	Le mélanome uvéal médecine/sciences ·Samar Alsafadi, Lenha Mobuchon, Manuel Rodrigues, Marc‐Henri Stern	2018	2
13	Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage Nature Communications ·Samar Alsafadi, Alexandre Houy, Aude Battistella, Tatiana Popova, Michel Wassef, Émilie Henry, Franck Tirode, Angelos Constantinou, Sophie Piperno‐Neumann, Sergio Roman‐Roman, Martin Dutertre, Marc‐Henri Stern	2016	270
14	Nuclear localization of the caspase-3-cleaved form of p73 in anoikis Oncotarget ·Samar Alsafadi, Sophie Tourpin, Budi Heryanto, Sophie Salomé‐Desnoulez, Gilles Vassal, Fabrice André, Jean‐Charles Ahomadegbe	2015	5
15	Chk1 as a new therapeutic target in triple-negative breast cancer The Breast ·Laurence Albigès, Aïcha Goubar, Véronique Scott, Cécile Vicier, Céline Lefèbvre, Samar Alsafadi, Frédéric Commo, Mahasti Saghatchian, Vladimir Lazar, Philippe Dessen, Suzette Delaloge, Fabrice André, Virginie Quidville	2014	46
16	Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy Cancer Research ·Virginie Quidville, Samar Alsafadi, Aïcha Goubar, Frédéric Commo, Véronique Scott, Catherine Pioche‐Durieu, Isabelle Girault, Sonia Baconnais, Éric Le Cam, Vladimir Lazar, Suzette Delaloge, Mahasti Saghatchian, Patricia Pautier, Philippe Morice, Mateus de Arêa Leão Martins, Stéphan Vagner, Fabrice André	2013	75
17	Retinoic Acid Receptor Alpha Amplifications and Retinoic Acid Sensitivity in Breast Cancers Clinical Breast Cancer ·Samar Alsafadi, Caroline Even, 윤화묵, Aïcha Goubar, Frédéric Commo, Véronique Scott, Virginie Quidville, Laurence Albigès, Maria Vittoria Dieci, Justine Guégan, Vladimir Lazar, Jean‐Charles Ahomadegbe, Suzette Delaloge, Fabrice André	2013	16
18	A Prospective Randomized Trial Evaluating Gene Expression Arrays to Select Neoadjuvant Chemotherapy Regimen for Operable Breast Cancer: First Report of the Remagus04 Trial Annals of Oncology ·Jean‐Yves Pierga, Bernard Asselain, Samar Alsafadi, Étienne Brain, F. Lerebours, Suzette Delaloge, David Gentien, Nicolas Servant, Brigitte Sigal‐Zafrani, Fabrice André	2012	1
19	P53 Family: At the Crossroads in Cancer Therapy Current Medicinal Chemistry ·Samar Alsafadi, Sophie Tourpin, Fabrice André, Gilles Vassal, J.C. Ahomadegbe	2009	25
20	Involvement of N-terminally truncated variants of p73, ΔTAp73, in head and neck squamous cell cancer: A comparison with p53 mutations Cell Cycle ·Tatyana A. Khristenko, Sophie Tourpin, Samar Alsafadi, Michel Barrois, Stéphane Temam, François Janot, Serge Koscielny, Jacques Bosq, Jean Bénard, Jean‐Charles Ahomadegbe	2008	12

About Samar Alsafadi

Samar Alsafadi is a scholar working on Ophthalmology, Cell Biology, Cancer Research, Oncology and Molecular Biology, having authored 24 papers that have together received 672 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (9 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (4 papers), RNA Research and Splicing (4 papers), RNA and protein synthesis mechanisms (4 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Ophthalmology (115 citations), Cancer Research (126 citations), Molecular Biology (525 citations), Hematology (66 citations) and Oncology (151 citations). Samar Alsafadi has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Sergio Roman‐Roman, Marc‐Henri Stern, Alexandre Houy, Tatiana Popova, Michel Wassef, Sophie Piperno‐Neumann, Angelos Constantinou, Aude Battistella, Martin Dutertre and Émilie Henry. Their work appears in journals such as Cancers, European Journal of Cancer, Cancer Research, JNCI Journal of the National Cancer Institute and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact